Lilly Asia & LYFE Join Ally Bridge in US Healthcare Play
16 Feb 2024
US$ 19.00
Lilly Asia Ventures (Lilly Asia) and LYFE Capital (LYFE), both China-based private equity firms, were party to the...
Related Publications
Subscribers’ Weekly for the week ending 16 May 2025...
Listen to Australia/New Zealand People on the Move (Subscribers' Weekly 16 May 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.